12
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Effect of Omeprazole on Antral Duodenogastric Reflux in Barrett Oesophagus

Pages 796-801 | Published online: 08 Jul 2009

References

  • Giuli R. The Barrett Committee meeting of the International Society for Diseases of the Oesophagus. Dis Esophagus 1996; 9:157–8.
  • Dent J, Bremner CG, Collen MJ, Haggitt RC, Spechler SJ. Working party report to the World Congresses of Gastroenterology, Sydney 1990: Barrett’s oesophagus. J Gastroenterol Hepatol 1991;6: 1–22.
  • Ter RB, Castell DO. Gastroesophageal reflux disease in patients with columnar-lined esophagus. Gastroenterol Clin North Am 1997;26:549–63.
  • Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 1996;111:1192–9.
  • Seto Y, Kobori O. Role of reflux oesophagitis and acid in the development of columnar epithelium in the rat oesophagus. Br J Surg 1993;80:467–70.
  • Sharma P, Sampliner RE, Camargo E. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett’s esophagus. Am J Gastroenterol 1997;92:582–5.
  • Wetscher GJ, Hinder RA, Smyrk T, Perdikis G, Adrian TE, Profanter C. Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux. Dig Dis Sci 1999;44:1132–5.
  • Wetscher GJ, Hinder RA, Kretchmar D, Stinson R, Perdikis G, Smyrk TC, et al. Duodenogastric reflux causes growth stimulation of foregut mucosa potentiated by gastric acid blockade. Dig Dis Sci 1996;41:2166–73.
  • Goldstein JL, Schlesinger PK, Mozwecz HL, Layden TJ. Esophageal mucosal resistance. A factor in esophagitis. Gastroenterol Clin North Am 1990;19:565–86.
  • Champion G, Richter JE, Vaezi MF, Singh S, Alexander R. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett’s esophagus. Gastroenterology 1994;107: 747–54.
  • Marshall REK, Anggiansah A, Manifold DK, Owen WA, Owen WJ. Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett’s oesophagus. Gut 1998;43: 603–6.
  • Manifold DK, Anggiansah A, Marshall REK, Owen WJ. Intragastric variation of duodenogastric reflux. Gut 1998;42 Suppl 1:A71.
  • Bechi P, Pucciani F, Baldini F, Cosi F, Falciai R, Mazzanti R, et al. Long-term ambulatory enterogastric reflux monitoring. Validation of a new fiberoptic technique. Dig Dis Sci 1993; 38:1297–306.
  • Bechi P, Falciai R, Baldini F, Cosi F, Pucciani F, Boscherini S. A new fibreoptic sensor for ambulatory enterogastric reflux detection. Fiberoptic Medical and Fluorescent Sensors and Applications 1992;1648:130–5.
  • Verdu EF, Fraser R, Murphy GM, Blum A, Armstrong D. The origin of nocturnal intragastric pH rises in healthy subjects. Scand J Gastroenterol 1995;30:935–43.
  • Waring JP, Legrand J, Chinichian A, Sanowski RA. Duodenogastric reflux in patients with Barrett’s esophagus. Dig Dis Sci 1990;35: 759–62.
  • Liron R, Parrilla P, Martinez de Haro LF, Ortiz A, Robles-Campos R, Lujan-Mompean JA, et al. Quantification of duodenogastric reflux in Barrett’s oesophagus. Am J Gastroenterol 1997;92:32–6.
  • Byrne JP, Romagnoli R, Bechi P, Attwood SE, Fuchs KH, Collard JM. Duodenogastric reflux of bile in health: the normal range. Physiol Meas 1999;20:149–58.
  • Kellow JE, Langeluddecke PM, Eckersley GM, Jones MP, Tennant CC. Effects of acute psychologic stress on small-intestinal motility in health and the irritable bowel syndrome. Scand J Gastroenterol 1992; 27:53–8.
  • Holtmann G, Singer MV, Kriebel R, Stacker KH, Goebell H. Differential effects of acute mental stress on interdigestive secretion of gastric acid, pancreatic enzymes, and gastroduodenal motility. Dig Dis Sci 1989;34:1701–7.
  • Vaezi MF, Lacamera RG, Richter JE. Validation studies of Bilitec 2000: an ambulatory duodenogastric reflux monitoring system. Am J Physiol 1994;267:G1050–7.
  • Manifold DK, Anggiansah A, Marshall REK, Owen WJ. Intrasubject variability of duodenogastric reflux. Gastroenterology 1998;114: A212.
  • De Caestecker JS. Measuring duodenogastro-oesophageal reflux (DGOR). Eur J Gastroenterol Hepatol 1997;9:1141–3.
  • Stipa F, Stein HJ, Feussner H, Kraemer S, Siewert JR. Assessment of non-acid esophageal reflux: comparison between long-term reflux aspiration test and fiberoptic bilirubin monitoring. Dis Esophagus 1997;10:24–8.
  • Girelli CM, Cuvello P, Limido E, Rocca F. Duodenogastric reflux: an update. Am J Gastroenterol 1996;91:648–53.
  • Wallmark B. Mechanism of action of omeprazole. Scand Gastroenterol Suppl 1986;21 Suppl 118:11–6.
  • Wallmark B. Omeprazole: mode of action and effect on acid secretion in animals. Scand Gastroenterol Suppl 1989;166:12–8.
  • Lamberts R, Creutzfeldt W, Struber HG, Brunner G, Solcia E. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology 1993; 104:1356–70.
  • Festen HPN, Tuynman HARE, Defize J, Pals G, Frants RR, Straub JP, et al. Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum pepsinogen I levels. Dig Dis Sci 1986;31:561–6.
  • Thompson JN, Barr JA, Collier N, Spencer J, Bush A, Cope L, et al. Basal, sham feed and pentagastrin stimulated gastric acid, pepsin and electrolytes after omeprazole 20 mg and 40 mg daily. Gut 1985;26:1018–24.
  • Nishina K, Mikawa K, Maekawa N, Takao Y, Shiga M, Obara H. A comparison of lansoprazole, omeprazole, and ranitidine for reducing preoperative gastric secretion in adult patients undergoing elective surgery. Anesth Analg 1996;82:832–6.
  • Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L. Effect of omeprazole—gastric proton pump inhibitor—on pentagastrin stimulated acid secretion in man. Gut 1983;24:270–6.
  • Rasmussen L, Qvist N, Oster-Jorgensen E, Rehfeld JF, Holst JJ, Pedersen SA. A double-blind placebo-controlled study on the effects of omeprazole on gut hormone secretion and gastric emptying rate. Scand J Gastroenterol 1997;32:900–5.
  • Rasmussen L, Oster-Jorgensen E, Qvist N, Hovendal C, Kraglund E, Olsen O. The effects of omeprazole on interdigestive motility and early post-prandial levels of gastrin and secretin. Scand J Gastroenterol 1992;27: 119–23.
  • Benini L, Castellani G, Bardelli E, Sembenini C, Brentegani MT, Caliari S. Omeprazole causes delay in gastric emptying of meals. Dig Dis Sci 1996;41:469–74.
  • Hongo M, Lin YF, Ujiie H, Okuno Y, Yamada M, Satake K. Acid suppression by omeprazole inhibits gastric emptying in normal subjects. Gastroenterology 1996;96:A218.
  • Rasmussen L, Oster-Jorgensen E, Qvist N, Kraglund K, Hovendal C, Pedersen SA. Short report: a double-blind placebo-controlled trial of omeprazole on characteristics of gastric emptying in healthy subjects. Aliment Pharmacol Ther 1991;5:85–9.
  • Horowitz M, Hetzel DJ, Buckle PJ, Chatterton BE, Shearman DJC. The effect of omeprazole on gastric emptying in patients with duodenal ulcer disease. Br J Clin Pharmacol 1984;18: 791–4.
  • Vinter-Jensen L, Kraglund K, Pedersen SA. A double-blind placebo controlled trial on characteristics of the migrating motor complex in healthy volunteers. Aliment Pharmacol Ther 1989;3: 615–20.
  • Hunt JN, Ramsbottom N. Effect of gastrin II on gastric emptying and secretion during a test meal. Br Med J 1967;4:386–90.
  • Hamilton SG, Sheiner HJ, Quinlan MF. Continuous monitoring of the effect of pentagastrin on gastric emptying of solid food in man. Gut 1976;17:273–9.
  • Brunner G, Hell M, Hengels KJ, Hennig U, Fuchs W. Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers. Digestion 1995;56: 137–44.
  • Fein M, Fuchs KH, Bohrer T, Freys SM, Thiede A. Fibre-optic technique for 24 hour bile reflux monitoring: standards and normal values for gastric monitoring. Dig Dis Sci 1996;41: 215–6.
  • Just RJ, Leite LP, Castell DO. Changes in overnight fasting intragastric pH show poor correlation with duodenogastric bile reflux in normal subjects. Am J Gastroenterol 1996;8:1567–70.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.